What are the liver function test (LFT) abnormalities in patients with leptospirosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Liver Function Tests in Leptospirosis

In leptospirosis, liver function tests characteristically show a disproportionately elevated bilirubin (often markedly elevated) with only mild-to-moderate elevations in transaminases (AST/ALT), creating a distinctive cholestatic-hepatocellular mixed pattern. 1

Characteristic LFT Pattern

Bilirubin Elevation

  • Bilirubin is typically high and often the most striking abnormality, frequently reaching levels consistent with clinical jaundice in severe cases (Weil's disease) 1
  • The elevated bilirubin is disproportionate to the degree of transaminase elevation, which helps distinguish leptospirosis from other causes of acute hepatitis 1

Transaminase Elevations

  • AST and ALT show only mild elevations despite significant clinical illness and jaundice 1
  • This mild transaminase elevation contrasts sharply with the marked hyperbilirubinemia, creating a distinctive biochemical signature 1
  • However, late in the disease course, progressive AST elevation (particularly when disproportionate to ALT) is an ominous prognostic sign 2

Alkaline Phosphatase

  • Alkaline phosphatase is typically raised, contributing to the cholestatic component of the LFT pattern 1

Critical Prognostic Indicators

AST/ALT Ratio as a Mortality Predictor

  • An AST/ALT ratio >3.0 predicts mortality in leptospirosis 2
  • Patients who survived had mean AST/ALT ratios of 1.86 ± 0.64, while those who died had ratios of 5.65 ± 2.27 (p=0.006) 2
  • All patients with ratios >3.0 died, while all patients with ratios <3.0 survived 2

Progressive AST Elevation

  • Late exaggerated AST elevation without concomitant ALT rise indicates acute deterioration with impending death 2
  • Serial monitoring of transaminases provides prognostic information beyond initial values 2

Other Laboratory Abnormalities

Renal Function

  • Biochemical evidence of renal failure is common, as leptospirosis causes hepatorenal syndrome 1
  • Urinalysis typically shows proteinuria and hematuria 1

Hematologic Findings

  • Polymorphonuclear leukocytosis is common 1
  • Thrombocytopenia occurs frequently 1
  • Anemia may develop if significant hemorrhage has occurred 1
  • Bleeding is due to capillary fragility, and coagulation tests are often normal despite hemorrhagic manifestations 1

Clinical Context and Timing

Disease Phases

  • Leptospirosis follows a biphasic course: initial bacteremic phase (4-7 days) followed by an immune phase (1-3 days later) 1
  • LFT abnormalities are most prominent during the immune phase when hepatorenal syndrome develops 1

Severity Spectrum

  • In mild cases, LFT abnormalities may be minimal or absent 1
  • In Weil's disease (severe leptospirosis), the combination of jaundice, renal failure, and hemorrhage with the characteristic LFT pattern is highly suggestive 1

Key Diagnostic Pitfalls

  • Do not expect severe transaminase elevations (>10 times upper limit of normal) in leptospirosis—such elevations suggest alternative diagnoses like ischemic hepatitis, acute viral hepatitis, or drug-induced liver injury 3
  • The mild transaminase elevation in leptospirosis contrasts with other causes of jaundice and can lead to diagnostic confusion if this pattern is not recognized 1
  • Monitor AST/ALT ratio serially—a rising ratio >3.0 mandates intensive care and consideration of renal replacement therapy 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Causes of Severe Liver Enzyme Elevations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.